medline.ch Neurologie Multiple Sklerose

	Cognitive impairment in multiple sclerosis: Where do we stand today? Mult Scler Amato MP, Portaccio E. PMID: 42334424 [PubMed - as supplied by publisher]
	Serum biomarkers remain stable after transitioning from intravenous to subcutaneous natalizumab in multiple sclerosis. J Neurol Muñoz-Vendrell A, Arroyo-Pereiro P, León I, Bau L, Matas E, Romero-Pinel L, Roca-Pereira S, Martínez-Yélamos A, Martínez-Yélamos S. PMID: 42332277 [PubMed - indexed for MEDLINE]
	Home-based exoskeleton use to improve quality of life in patients with multiple sclerosis: study protocol of a multicentre, randomised, cross-over trial. BMJ Open Leblong E, Billot M, Cecile D, Gelis A, Mickaël D, Jacquin-Courtois S, Gross R, Le Meur C, Linda B, Carole A, Benoit N, Bastien F, Philippe G. PMID: 42331578 [PubMed - in process]
	A blood transcriptomic signature anchored to central nervous system pathology enables noninvasive detection of multiple sclerosis. Neurobiol Dis Zhu Z, Huang LP, Jin HY, Zhou HQ, Zhang JW. PMID: 42331233 [PubMed - as supplied by publisher]
	Serum 25-hydroxyvitamin D and neurological disability in multiple sclerosis: a cross-sectional study in a Libyan multicenter cohort. Acta Neurol Belg Alrouwab O, Benhizia H, Amara I. PMID: 42329560 [PubMed - as supplied by publisher]
	Efficacy and Safety of Patients With Relapsing Multiple Sclerosis Switching to Ocrelizumab Due to Suboptimal Treatment Response: Results of the 4-Year CASTING-LIBERTO Trial. Eur J Neurol Vermersch P, Benedict RHB, Van Wijmeersch B, Cutter G, Kister L, Oreja-Guevara C, Siva A, Wiendl H, Wuerfel J, El Azzouzi B, Kuenzel T, Buffels R, Craveiro L, Dirks P, Comi G. PMID: 42328798 [PubMed - indexed for MEDLINE]
	Residual inflammation in the cerebrospinal fluid after short- and long-term natalizumab treatment in relapsing-remitting multiple sclerosis. Front Immunol Buhelt S, Hansen MB, Søndergaard HB, El Mahdaoui S, Hansen MM, Mahler MR, Romme Christensen J, Sellebjerg F. PMID: 42327769 [PubMed - indexed for MEDLINE]
	Implementing Co-innovation to Develop an Accessible, Web-Based Exercise Program for People with Multiple Sclerosis. Arch Rehabil Res Clin Transl Willingham TB, Stowell JF, Moldavskiy M, Backus D. PMID: 42326597 [PubMed]
	The Multiple Sclerosis Severity Allele rs10191329(A) and Cognitive Function: A UK Biobank Study. Ann Clin Transl Neurol Zimianiti I, Waters S, Harroud A, Stridh P, Dobson R, Jacobs BM. PMID: 42324924 [PubMed - as supplied by publisher]
	Aging with multiple sclerosis and associated prevalence, incidence, comorbidities and healthcare utilization patterns in a population based study. Sci Rep Staun-Ram E, Neter E, Glass-Marmor L, Stein N, Miller A. PMID: 42324325 [PubMed - as supplied by publisher]
	Natalizumab is associated with improved relapse outcomes and lower healthcare utilization versus ocrelizumab in treatment-naÃ¯ve people with multiple sclerosis. J Med Econ Kaplan J, Beenstock D, Belkin M, Crayton H, Eckstein C, Fredericks R, Bian B, Belviso N, Ni D, Rutledge D. PMID: 42323726 [PubMed - indexed for MEDLINE]
	Pregnancy outcomes in patients with multiple sclerosis with or without exposure to disease-modifying treatment: A retrospective cohort study on Iranian population. Mult Scler Relat Disord Paybast S, Asl Fallah E, Sahraian MA, Azimi AR. PMID: 42322960 [PubMed - as supplied by publisher]
	Exploratory analysis of pupillography-based machine learning for assessing autonomic dysfunction in multiple sclerosis. Mult Scler Relat Disord Parmak Yener N, F, Sefero, Karg, K. PMID: 42322958 [PubMed - as supplied by publisher]
	Prognostic value of neurofilament light chain protein and glial fibrillary acidic protein in multiple sclerosis subtypes and disease activity patterns: a systematic review and meta-analysis. Neurol Sci Yang C, Jiang C, Wang Y, Hu Y, Li Y, Zhou P, Wang Y. PMID: 42322442 [PubMed - indexed for MEDLINE]
	Co-development of a protocol for a randomised controlled feasibility trial of CIRCuiTSâ„¢ cognitive remediation therapy for people with multiple sclerosis. Pilot Feasibility Stud Thomas RJ, Cella M, Brex PA, Silber E, Fifield K, Burke P, Summers M, Simblett S, Wykes T. PMID: 42321924 [PubMed - as supplied by publisher]
	Neurofilament light chain and glial fibrillary acidic protein as biomarkers of peripheral nervous system involvement in multiple sclerosis: diagnostic and prognostic evaluation. BMC Neurol Flintere-Flinte A, Krutovs V, Pantelejeva E, Blennow K, Zetterberg H, Zolovs M, Kenina V. PMID: 42321679 [PubMed - as supplied by publisher]
	Adjunctive Dulaglutide in Relapsing-Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial. Neurol Ther , Rádiková , Kollár B, Kut, Penesová A, Havranová A, Imrich R, Vl, , Krastev G, Tur. PMID: 42321509 [PubMed - as supplied by publisher]
	Epstein-Barr virus and multiple sclerosis: from associations to mechanisms to potential therapies. Lancet Neurol Lünemann JD, Münz C. PMID: 42320500 [PubMed - as supplied by publisher]
	Effects of high-dose vitamin D supplementation in patients with multiple sclerosis: A systematic review of efficacy and safety. Mult Scler Relat Disord Ghamdi KA, Alqarni M, Alamri Z, Wahhas MA, Alkhaldi M, Alsanni A, Alhawaj AF. PMID: 42320168 [PubMed - as supplied by publisher]
	Pearls & Oy-sters: Radiologic Lag in Pediatric-Onset Multiple Sclerosis. Neurology Mirchi A, Vossough A, Liu GT, Narula S. PMID: 42320011 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 44285

Seite 1 von 2215

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung